UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2020	$ 36	$ 115	$ (8,281)	$ 110,952	$ 102,822
Equity Balance, shares at Dec. 31, 2020	3,643
Common stock issued upon exercise of employee stock options	$ 0	89	0	0	89
Common stock issued upon exercise of employee stock options, shares	3
Stock option compensation expense	$ 0	41	0	0	41
Foreign currency translation adjustment	0	0	(54)	0	(54)
Common stock dividends	0	0	0	(1,039)	(1,039)
Net income	0	0	0	3,024	3,024
Equity Balance, value at Mar. 31, 2021	$ 36	245	(8,335)	112,937	104,883
Equity Balance, shares at Mar. 31, 2021	3,646
Equity Balance, value at Dec. 31, 2020	$ 36	115	(8,281)	110,952	102,822
Equity Balance, shares at Dec. 31, 2020	3,643
Foreign currency translation adjustment					(5)
Net income					6,450
Equity Balance, value at Jun. 30, 2021	$ 36	289	(8,286)	115,326	107,365
Equity Balance, shares at Jun. 30, 2021	3,646
Equity Balance, value at Mar. 31, 2021	$ 36	245	(8,335)	112,937	104,883
Equity Balance, shares at Mar. 31, 2021	3,646
Common stock issued upon exercise of employee stock options	$ 0	3	0	0	3
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	41	0	0	41
Foreign currency translation adjustment	0	0	49	0	49
Common stock dividends	0	0	0	(1,037)	(1,037)
Net income	0	0	0	3,426	3,426
Equity Balance, value at Jun. 30, 2021	$ 36	289	(8,286)	115,326	107,365
Equity Balance, shares at Jun. 30, 2021	3,646
Equity Balance, value at Dec. 31, 2021	$ 37	841	(9,054)	115,314	107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Common stock issued upon exercise of employee stock options	$ 0	19	0	0	19
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	43	0	0	43
Foreign currency translation adjustment	0	0	(506)	0	(506)
Common stock dividends	0	0	0	(1,060)	(1,060)
Net income	0	0	0	3,534	3,534
Equity Balance, value at Mar. 31, 2022	$ 37	903	(9,560)	117,789	109,168
Equity Balance, shares at Mar. 31, 2022	3,655
Equity Balance, value at Dec. 31, 2021	$ 37	841	(9,054)	115,314	107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Foreign currency translation adjustment					(2,804)
Net income					7,638
Equity Balance, value at Jun. 30, 2022	$ 36	0	(11,858)	119,293	107,471
Equity Balance, shares at Jun. 30, 2022	3,625
Equity Balance, value at Mar. 31, 2022	$ 37	903	(9,560)	117,789	109,168
Equity Balance, shares at Mar. 31, 2022	3,655
Common stock issued upon exercise of employee stock options	$ 0	4	0	0	4
Common stock issued upon exercise of employee stock options, shares	0
Stock option compensation expense	$ 0	40	0	0	40
Common stock purchased and retired	$ 0	(947)	0	(1,548)	(2,495)
Common stock purchased and retired, shares	(30)
Foreign currency translation adjustment	$ 0	0	(2,298)	0	(2,298)
Common stock dividends	0	0	0	(1,051)	(1,051)
Net income	0	0	0	4,103	4,103
Equity Balance, value at Jun. 30, 2022	$ 36	$ 0	$ (11,858)	$ 119,293	$ 107,471
Equity Balance, shares at Jun. 30, 2022	3,625